世界の抗うつ薬市場は2023年に約170億米ドルと評価され、2024年から2032年の予測期間にわたって3.0%を超える健全な成長率で成長すると予想されています。
抗うつ薬は、悲しみの感情が持続し、かつて楽しんでいた活動への興味が失われる状態であるうつ病の治療に使用される薬の一種です。また、不安や強迫性障害などの他の症状にも役立ちます。さらに、心的外傷後ストレス障害（PTSD）、強迫性障害（OCD）、全般性不安障害など、さまざまな障害がこれらの薬で治療されます。慢性疼痛患者も治療されます。処方抗うつ薬は、うつ病の第一選択治療として、単独で、または行動療法や身体活動と組み合わせて使用できます。さらに、抗うつ薬の開発への投資の増加と人々の病気の蔓延に対する意識の高まりにより、世界の抗うつ薬市場への注目が高まっています。
世界の抗うつ薬市場は、うつ病に関する意識の高まり、うつ病の有病率の増加、および世界中のヘルスケア部門における研究開発活動の進歩によって推進されています。世界保健機関（WHO）によると、2021年には成人の約5％がうつ病と診断されています。抗うつ薬は、脳内のさまざまなホルモンと化学物質のバランスを維持します。さらに、強迫性障害、大うつ病性障害、全般性不安障害などの生命を脅かす疾患の有病率の上昇が、市場の成長を牽引しています。さらに、高齢者人口の増加と抗うつ薬の開発承認数の増加は、市場に新たな機会を生み出しています。ただし、薬物に関連する副作用と厳格な規制遵守は、2024年から2032年の予測期間中に市場全体の需要を妨げることになります。
抗うつ薬の世界市場調査において考慮した主要地域には、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他世界のその他の地域が含まれます。2023年、北アメリカは、うつ病の有病率の上昇、医薬品承認数の増加、主要な市場企業の存在、同地域のヘルスケア部門における研究開発活動の開発および投資のためのイニシアチブの上昇により、収益の面で最大の地域市場でした。しかし、アジア太平洋地域は、精神障害の有病率の増加、うつ病に関する意識の高まり、医療費の増加、臨床試験数の増加などの要因により、予測期間の2024年から2032年にかけて最も速い速度で発展することが期待されています。
目次
Table of Contents
Chapter 1. Global Antidepressant Drugs Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer's Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Global Antidepressant Drugs Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product
2.3.2. By Depressive Disorder
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global Antidepressant Drugs Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global Antidepressant Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Antidepressant Drugs Market Size & Forecasts by Product 2022-2032
5.1. Tricyclic Antidepressants
5.2. Selective Serotonin Reuptake Inhibitors
5.3. Serotonin Norepinephrine Reuptake Inhibitors
5.4. Monoamine Oxidase Inhibitors
5.5. Serotonin Antagonist and Reuptake Inhibitors
5.6. Others
Chapter 6. Global Antidepressant Drugs Market Size & Forecasts by Depressive Disorder 2022-2032
6.1. Major Depressive Disorder
6.2. Obsessive-Compulsive Disorder
6.3. Generalized Anxiety Disorder
6.4. Panic Disorder
6.5. Others
Chapter 7. Global Antidepressant Drugs Market Size & Forecasts by Region 2022-2032
7.1. North America Antidepressant Drugs Market
7.1.1. U.S. Antidepressant Drugs Market
7.1.1.1. Product breakdown size & forecasts, 2022-2032
7.1.1.2. Depressive Disorder breakdown size & forecasts, 2022-2032
7.1.2. Canada Antidepressant Drugs Market
7.2. Europe Antidepressant Drugs Market
7.2.1. U.K. Antidepressant Drugs Market
7.2.2. Germany Antidepressant Drugs Market
7.2.3. France Antidepressant Drugs Market
7.2.4. Spain Antidepressant Drugs Market
7.2.5. Italy Antidepressant Drugs Market
7.2.6. Rest of Europe Antidepressant Drugs Market
7.3. Asia-Pacific Antidepressant Drugs Market
7.3.1. China Antidepressant Drugs Market
7.3.2. India Antidepressant Drugs Market
7.3.3. Japan Antidepressant Drugs Market
7.3.4. Australia Antidepressant Drugs Market
7.3.5. South Korea Antidepressant Drugs Market
7.3.6. Rest of Asia Pacific Antidepressant Drugs Market
7.4. Latin America Antidepressant Drugs Market
7.4.1. Brazil Antidepressant Drugs Market
7.4.2. Mexico Antidepressant Drugs Market
7.4.3. Rest of Latin America Antidepressant Drugs Market
7.5. Middle East & Africa Antidepressant Drugs Market
7.5.1. Saudi Arabia Antidepressant Drugs Market
7.5.2. South Africa Antidepressant Drugs Market
7.5.3. Rest of Middle East & Africa Antidepressant Drugs Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Alkermes Plc
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. AbbVie Inc.
8.3.3. Eli Lilly and Company
8.3.4. F. Hoffmann-La Roche Ltd.
8.3.5. GlaxoSmithKline, Inc.
8.3.6. H. Lundbeck A/S
8.3.7. Merck KGAA
8.3.8. Pfizer Inc.
8.3.9. Teva Pharmaceutical Industries Ltd. (Actavis Generics)
8.3.10. Takeda Pharmaceutical Limited Company
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
LIST OF TABLES
TABLE 1. Global Antidepressant Drugs market, report scope
TABLE 2. Global Antidepressant Drugs market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Antidepressant Drugs market estimates & forecasts by Product 2022-2032 (USD Billion)
TABLE 4. Global Antidepressant Drugs market estimates & forecasts by Depressive Disorder 2022-2032 (USD Billion)
TABLE 5. Global Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 6. Global Antidepressant Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Antidepressant Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Antidepressant Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Antidepressant Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Antidepressant Drugs market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Antidepressant Drugs market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 21. UK Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 22. UK Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 23. UK Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 24. Germany Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 25. Germany Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 26. Germany Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 27. France Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 28. France Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 29. France Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 30. Italy Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 31. Italy Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 32. Italy Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 33. Spain Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 34. Spain Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 35. Spain Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 36. RoE Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 37. RoE Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 38. RoE Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 39. China Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 40. China Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 41. China Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 42. India Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 43. India Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 44. India Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 45. Japan Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 46. Japan Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 47. Japan Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 48. Australia Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 49. Australia Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 50. Australia Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 51. South Korea Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 52. South Korea Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 53. South Korea Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 54.
TABLE 55. RoAPAC Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 56. RoAPAC Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 57. RoAPAC Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 58. Brazil Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 59. Brazil Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 60. Brazil Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 61. Mexico Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 62. Mexico Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 63. Mexico Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 64. RoLA Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 65. RoLA Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 66. RoLA Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 67. Saudi Arabia Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 68. Saudi Arabia Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 69. Saudi Arabia Antidepressant Drugs market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 70. South Africa Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 71.
TABLE 72. South Africa Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 73. South Africa Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 74. RoMEA Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 75. RoMEA Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 76. RoMEA Antidepressant Drugs market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 77. List of secondary sources, used in the study of Global Antidepressant Drugs Market.
TABLE 78. List of primary sources, used in the study of Global Antidepressant Drugs Market.
TABLE 79. Years considered for the study.
TABLE 80. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Antidepressant Drugs market, research methodology
FIG 2. Global Antidepressant Drugs market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Antidepressant Drugs market, key trends 2023
FIG 5. Global Antidepressant Drugs market, growth prospects 2022-2032
FIG 6. Global Antidepressant Drugs market, porters 5 force model
FIG 7. Global Antidepressant Drugs market, pestel analysis
FIG 8. Global Antidepressant Drugs market, value chain analysis
FIG 9. Global Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Antidepressant Drugs market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Antidepressant Drugs market, regional snapshot 2022 & 2032
FIG 15. North America Antidepressant Drugs market 2022 & 2032 (USD Billion)
FIG 16. Europe Antidepressant Drugs market 2022 & 2032 (USD Billion)
FIG 17. Asia pacific Antidepressant Drugs market 2022 & 2032 (USD Billion)
FIG 18. Latin America Antidepressant Drugs market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Antidepressant Drugs market 2022 & 2032 (USD Billion)
